1
|
Roy P, Kandel R, Sawant N, Singh KP. Estrogen-induced reactive oxygen species, through epigenetic reprogramming, causes increased growth in breast cancer cells. Mol Cell Endocrinol 2024; 579:112092. [PMID: 37858609 DOI: 10.1016/j.mce.2023.112092] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/17/2023] [Revised: 10/14/2023] [Accepted: 10/16/2023] [Indexed: 10/21/2023]
Abstract
Despite the progress made in cancer diagnosis and treatment, breast cancer remains the second leading cause of cancer-related death among the women. Exposure to elevated levels of endogenous estrogen or environmental estrogenic chemicals is an important risk factor for breast cancer. Estrogen metabolites and ROS generated during estrogen metabolism are known to play a critical role in estrogen carcinogenesis. However, the molecular mechanisms through which estrogen-induced ROS regulate gene expression is not clear. Epigenetic changes of DNA methylation and histone modifications are known to regulate genes expression. Therefore, the objective of this study was to evaluate whether estrogen-induced ROS, through aberrant expression of epigenetic regulatory genes and epigenetic reprogramming, causes growth of breast cancer cells. Estrogen responsive MCF-7 and T47D human breast cancer cells were exposed to natural estrogen 17 beta-estradiol (E2) and synthetic estrogen Diethylstilbestrol (DES) both alone and in combination with antioxidant N-acetyl cysteine. Effects of NAC-mediated scavenging of estrogen-induced ROS on cell growth, gene expression, and histone modifications were measured. The result of MTT and cell cycle analysis revealed significant abrogation of E2 and DES-induced growth by scavenging ROS through NAC. E2 and DES caused significant changes in expression of epigenetic regulatory genes for DNA methylation and histone modifications as well as changes in both gene activating and repressive marks in the Histone H3. NAC restored the expression of epigenetic regulatory genes and changes in histone marks. Novel findings of this study suggest that estrogen can induce growth of breast cancer cells through ROS-dependent regulation of epigenetic regulatory genes and epigenetic reprogramming of histone marks.
Collapse
Affiliation(s)
- Priti Roy
- Department of Environmental Toxicology, Texas Tech University, Lubbock, TX, 79409, USA
| | - Ramji Kandel
- Department of Environmental Toxicology, Texas Tech University, Lubbock, TX, 79409, USA
| | - Neha Sawant
- Department of Environmental Toxicology, Texas Tech University, Lubbock, TX, 79409, USA
| | - Kamaleshwar P Singh
- Department of Environmental Toxicology, Texas Tech University, Lubbock, TX, 79409, USA.
| |
Collapse
|
2
|
Nicolella HD, de Assis S. Epigenetic Inheritance: Intergenerational Effects of Pesticides and Other Endocrine Disruptors on Cancer Development. Int J Mol Sci 2022; 23:4671. [PMID: 35563062 PMCID: PMC9102839 DOI: 10.3390/ijms23094671] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2022] [Revised: 04/08/2022] [Accepted: 04/20/2022] [Indexed: 12/14/2022] Open
Abstract
Parental environmental experiences affect disease susceptibility in the progeny through epigenetic inheritance. Pesticides are substances or mixtures of chemicals-some of which are persistent environmental pollutants-that are used to control pests. This review explores the evidence linking parental exposure to pesticides and endocrine disruptors to intergenerational and transgenerational susceptibility of cancer in population studies and animal models. We also discuss the impact of pesticides and other endocrine disruptors on the germline epigenome as well as the emerging evidence for how epigenetic information is transmitted between generations. Finally, we discuss the importance of this mode of inheritance in the context of cancer prevention and the challenges ahead.
Collapse
Affiliation(s)
- Heloiza Diniz Nicolella
- Georgetown University Medical Center, Washington, DC 20057, USA;
- Lombardi Comprehensive Cancer Center, Washington, DC 20057, USA
| | - Sonia de Assis
- Georgetown University Medical Center, Washington, DC 20057, USA;
- Lombardi Comprehensive Cancer Center, Washington, DC 20057, USA
| |
Collapse
|
3
|
Sandvei MS, Opdahl S, Valla M, Lagiou P, Vesterfjell EV, Rise TV, Overrein TS, Skjervold AH, Engstrøm MJ, Bofin AM, Vatten LJ. The association of women's birth size with risk of molecular breast cancer subtypes: a cohort study. BMC Cancer 2021; 21:299. [PMID: 33757450 PMCID: PMC7989032 DOI: 10.1186/s12885-021-08027-9] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/25/2020] [Accepted: 03/12/2021] [Indexed: 11/17/2022] Open
Abstract
Background Because birth size appears to be positively associated with breast cancer risk, we have studied whether this risk may differ according to molecular breast cancer subtypes. Methods A cohort of 22,931 women born 1920–1966 were followed up for breast cancer occurrence from 1961 to 2012, and 870 were diagnosed during follow-up. Archival diagnostic material from 537 patients was available to determine molecular breast cancer subtype, specified as Luminal A, Luminal B (human epidermal growth factor receptor 2 (HER2)-), Luminal B (HER2+), HER2 type, and Triple negative (TN) breast cancer. Information on the women’s birth weight, birth length and head circumference at birth was used to estimate hazard ratios (HR) with 95% confidence intervals (CI) for each molecular subtype, applying Cox regression, and stratified by maternal height. Results Birth length (per 2 cm increments) was positively associated with Luminal A (HR = 1.2, 95% CI, 1.0–1.3), Luminal B (HER2+) (HR = 1.3, 95% CI, 1.0–1.7), and TN breast cancer (HR = 1.4, 95% CI, 1.0–1.9). No clear association was found for birth weight and head circumference. The positive associations of birth length were restricted to women whose mothers were relatively tall (above population median). Conclusion We found a positive association of birth length with risk of Luminal A, Luminal B (HER2+) and TN breast cancer that appears to be restricted to women whose mothers were relatively tall. This may support the hypothesis that breast cancer risk is influenced by determinants of longitudinal growth and that this finding deserves further scrutiny.
Collapse
Affiliation(s)
- Marie S Sandvei
- Faculty of Medicine and Health Sciences, Department of Public Health and Nursing, Norwegian University of Science and Technology, Post box 8905, N-7491, Trondheim, Norway.,The Cancer Clinic, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway
| | - Signe Opdahl
- Faculty of Medicine and Health Sciences, Department of Public Health and Nursing, Norwegian University of Science and Technology, Post box 8905, N-7491, Trondheim, Norway
| | - Marit Valla
- NTNU, Faculty of Medicine and Health Sciences, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Post box 8905, N-7491, Trondheim, Norway.,Department of Pathology, St. Olavs Hospital HF, Trondheim University Hospital, Postboks 3250 Torgarden, 7006, Trondheim, Norway
| | - Pagona Lagiou
- Department of Hygiene, Epidemiology and Medical Statistics, School of Medicine, National and Kapodistrian University of Athens, 75 M. Asias Street, Goudi, GR-115 27, Athens, Greece.,Department of Epidemiology, Harvard School of Public Health, Boston, USA
| | - Ellen Veronika Vesterfjell
- Department of Pathology, St. Olavs Hospital HF, Trondheim University Hospital, Postboks 3250 Torgarden, 7006, Trondheim, Norway
| | - Tor Vikan Rise
- NTNU, Faculty of Medicine and Health Sciences, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Post box 8905, N-7491, Trondheim, Norway.,Department of Pathology, St. Olavs Hospital HF, Trondheim University Hospital, Postboks 3250 Torgarden, 7006, Trondheim, Norway
| | - Tina Syvertsen Overrein
- Department of Pathology, St. Olavs Hospital HF, Trondheim University Hospital, Postboks 3250 Torgarden, 7006, Trondheim, Norway
| | - Anette H Skjervold
- NTNU, Faculty of Medicine and Health Sciences, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Post box 8905, N-7491, Trondheim, Norway
| | - Monica J Engstrøm
- NTNU, Faculty of Medicine and Health Sciences, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Post box 8905, N-7491, Trondheim, Norway.,Department of Breast and Endocrine Surgery, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway
| | - Anna M Bofin
- NTNU, Faculty of Medicine and Health Sciences, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Post box 8905, N-7491, Trondheim, Norway
| | - Lars J Vatten
- Faculty of Medicine and Health Sciences, Department of Public Health and Nursing, Norwegian University of Science and Technology, Post box 8905, N-7491, Trondheim, Norway.
| |
Collapse
|
4
|
Xu Z, Sun T, He H, Liu W, Fan L, Zhao L, Wu X, Han Z, Zhang Y, Wang Q, Ning B, Gao Z. Simultaneous detection of diethylstilbestrol and estradiol residues with a single immunochromatographic assay strip. Food Sci Nutr 2021; 9:1824-1830. [PMID: 33747491 PMCID: PMC7958558 DOI: 10.1002/fsn3.2127] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2020] [Revised: 12/18/2020] [Accepted: 12/26/2020] [Indexed: 01/17/2023] Open
Abstract
An immunochromatographic assay (ICA) based on competitive format was developed and validated for simultaneously rapid and sensitive detection of diethylstilbestrol (DES) and estradiol (E2) in milk and tissue samples. For this purpose, two monoclonal antibodies raised against those two estrogens were conjugated to gold nanoparticles and were applied to the conjugate pads of the test strip. The competitors of the DES-BSA/E2-BSA conjugates were immobilized onto a nitrocellulose membrane at two detection zones to form T1 and T2, respectively. The immunochromatographic assay had a visual detection limit of DES at 30 ng/g in milk powder, 25 ng/g in liquid milk, and 25 ng/g in shrimp tissue, respectively, and the results can be judged within 7-10 min. The visual detection limit of E2 was 75 ng/g in milk powder, 65 ng/g in liquid milk, and 60 ng/g in shrimp tissue, respectively, and the results can be judged within 3-4 min. It had advantages in easy operation without requiring sophisticated equipment and specialized skills. By testing thirty milk and shrimp tissue samples from the local market, the method was compared with the HPLC-MS / MS method, and there was no statistical difference between the two methods. Furthermore, the immunochromatographic assay had good specificity, simple procedure, and low cost. This protocol was well suited for the food safety monitoring and early warning.
Collapse
Affiliation(s)
- Zehua Xu
- Tianjin Institute of Environmental and Operational MedicineTianjinChina
| | - Tieqiang Sun
- Tianjin Institute of Environmental and Operational MedicineTianjinChina
| | - Hongwei He
- Tianjin Institute of Environmental and Operational MedicineTianjinChina
| | - Wentao Liu
- Tianjin Institute of Environmental and Operational MedicineTianjinChina
| | - Longxing Fan
- Tianjin Institute of Environmental and Operational MedicineTianjinChina
| | - Lingdi Zhao
- Tianjin Institute of Environmental and Operational MedicineTianjinChina
| | - Xinglin Wu
- Tianjin Institute of Environmental and Operational MedicineTianjinChina
| | - Zhenyu Han
- Tianjin Institute of Environmental and Operational MedicineTianjinChina
| | - Yingcun Zhang
- Tianjin Institute of Environmental and Operational MedicineTianjinChina
| | - Qiangqiang Wang
- Tianjin Institute of Environmental and Operational MedicineTianjinChina
| | - Baoan Ning
- Tianjin Institute of Environmental and Operational MedicineTianjinChina
| | - Zhixian Gao
- Tianjin Institute of Environmental and Operational MedicineTianjinChina
| |
Collapse
|
5
|
Katsoulis M, La Vecchia C, Trichopoulou A, Lagiou P. Maternal height and breast cancer risk: results from a study nested within the EPIC-Greece cohort. Eur J Epidemiol 2017; 32:457-463. [PMID: 28417273 DOI: 10.1007/s10654-017-0245-z] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2016] [Accepted: 04/06/2017] [Indexed: 12/27/2022]
Abstract
The positive association of adult height with breast cancer (BC) risk has been hypothesized to be partly accounted for by an association of this risk with maternal height (operating in utero to modify hormone effects). In a case-control study (271 BC patients and 791 controls) nested within the EPIC-Greece cohort, we applied mediation analysis to calculate the direct and indirect (through the woman's own height) effect of maternal height on BC risk. Per 5 cm increase in maternal height and depending on its reference value: the indirect effect odds ratio ranges from 1.02 to 1.07; the direct effect odds ratio from 1.06 to 1.11; and the total (direct and indirect effects) from 1.08 to 1.19. The effect sizes consistently increased for higher reference categories of maternal height, but did not generally reach statistical significance, possibly due to the limited sample size.
Collapse
Affiliation(s)
- Michail Katsoulis
- Hellenic Health Foundation, 13 Kaisareias and Alexandoupoleos Street, 115 27, Athens, Greece.,Farr Institute of Health Informatics Research, University College London, 222 Euston Road, London, NW1 2DA, UK
| | - Carlo La Vecchia
- Hellenic Health Foundation, 13 Kaisareias and Alexandoupoleos Street, 115 27, Athens, Greece.,Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Via Vanzetti, 5, 20133, Milan, Italy
| | - Antonia Trichopoulou
- Hellenic Health Foundation, 13 Kaisareias and Alexandoupoleos Street, 115 27, Athens, Greece.
| | - Pagona Lagiou
- Hellenic Health Foundation, 13 Kaisareias and Alexandoupoleos Street, 115 27, Athens, Greece.,Department of Hygiene, Epidemiology and Medical Statistics, School of Medicine, National and Kapodistrian University of Athens, 75 M. Asias Street, Goudi, 115 27, Athens, Greece.,Department of Epidemiology, Harvard T. H. Chan School of Public Health, 677 Huntington Avenue, Boston, MA, 02115, USA
| |
Collapse
|
6
|
Tournaire M, Devouche E, Espié M, Asselain B, Levadou A, Cabau A, Dunbavand A, Grosclaude P, Epelboin S. Cancer Risk in Women Exposed to Diethylstilbestrol in Utero. Therapie 2015; 70:433-41. [DOI: 10.2515/therapie/2015030] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/06/2015] [Accepted: 03/16/2015] [Indexed: 11/20/2022]
|
7
|
Ahrenfeldt LJ, Skytthe A, Möller S, Czene K, Adami HO, Mucci LA, Kaprio J, Petersen I, Christensen K, Lindahl-Jacobsen R. Risk of Sex-Specific Cancers in Opposite-Sex and Same-Sex Twins in Denmark and Sweden. Cancer Epidemiol Biomarkers Prev 2015; 24:1622-8. [PMID: 26282631 DOI: 10.1158/1055-9965.epi-15-0317] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2015] [Accepted: 07/29/2015] [Indexed: 01/12/2023] Open
Abstract
BACKGROUND Increasing evidence shows that some cancers originate in utero. It is hypothesized that elevated exposure to some steroid hormones might increase cancer risk and that hormone transfer between twin fetuses could result in different prenatal exposure to testosterone. METHODS This large-scale prospective twin study compared opposite-sex (OS) and same-sex (SS) twins to test the impact of intrauterine exposures on cancer risk. On the basis of the Danish and Swedish twin and cancer registries, we calculated incidence rate ratios for OS and SS twins, whereas standardized incidence ratios (SIR) with 95% confidence intervals (CI) were calculated for OS/SS twins compared with the general population. RESULTS A total of 18,001 cancers were identified during 1943-2009. No significant differences were observed between OS and SS twins, neither for the sex-specific cancers nor for cancer at all sites. All-cause cancer was slightly reduced for OS and SS twins compared with the general population, significant for OS males (SIR, 0.95; 95% CI, 0.92-0.98) and for SS males and females (SIR, 0.97; 95% CI, 0.94-0.99). CONCLUSIONS Our data suggest that having a male co-twin-which may entail higher exposure to prenatal testosterone-does not increase the risk of sex-specific cancers in OS females. Furthermore, the study supports that twinning per se is not a risk factor of cancer. IMPACT Findings are reassuring, as they fail to provide evidence for the hypothesis that endocrine or other difference in the in utero milieu affects the risk of sex-specific cancers.
Collapse
Affiliation(s)
- Linda J Ahrenfeldt
- The Danish Twin Registry, Department of Public Health, University of Southern Denmark, Odense C, Denmark.
| | - Axel Skytthe
- The Danish Twin Registry, Department of Public Health, University of Southern Denmark, Odense C, Denmark
| | - Sören Möller
- The Danish Twin Registry, Department of Public Health, University of Southern Denmark, Odense C, Denmark
| | - Kamila Czene
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
| | - Hans-Olov Adami
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts
| | - Lorelei A Mucci
- Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts
| | - Jaakko Kaprio
- Department of Public Health and Institute for Molecular Medicine, University of Helsinki, Helsinki, Finland. Department of Health, National Institute for Health and Welfare, Helsinki, Finland
| | - Inge Petersen
- The Danish Twin Registry, Department of Public Health, University of Southern Denmark, Odense C, Denmark
| | - Kaare Christensen
- The Danish Twin Registry, Department of Public Health, University of Southern Denmark, Odense C, Denmark. Department of Clinical Biochemistry and Pharmacology and Department of Clinical Genetics, Odense University Hospital, Odense, Denmark
| | - Rune Lindahl-Jacobsen
- The Danish Twin Registry, Department of Public Health, University of Southern Denmark, Odense C, Denmark. Max-Planck Odense Center on the Biodemography of Aging, University of Southern Denmark, Odense C, Denmark
| |
Collapse
|
8
|
Sandvei MS, Lagiou P, Romundstad PR, Trichopoulos D, Vatten LJ. Size at birth and risk of breast cancer: update from a prospective population-based study. Eur J Epidemiol 2015; 30:485-92. [PMID: 26026723 DOI: 10.1007/s10654-015-0045-2] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2015] [Accepted: 05/16/2015] [Indexed: 12/30/2022]
Abstract
Birth size variables (birth weight, birth length and head circumference) have been reported to be positively associated with adult breast cancer risk, whereas a possible association of placental weight has not been adequately studied. It has also been suggested that maternal height may modify the association of birth size with adult breast cancer risk, but this has not been studied in detail. We updated a long-term follow-up of 22,931 Norwegian women (average of 51 years of follow up during which 870 women were diagnosed with breast cancer) and assessed placental weight in relation to breast cancer risk, in addition to providing updated analyses on breast cancer risk in relation to birth weight, birth length and head circumference. Placental weight was not associated with risk for breast cancer in adulthood, but there was a positive association of breast cancer risk with birth length (HR 1.13, 95% CI 1.05-1.21, per 2 cm increment), though not with birth weight (HR 1.02, 95% CI 0.95-1.10 per 0.5 kg increment). For birth length, the graded increase in risk was particularly strong among women whose mothers were relatively tall (p for trend, 0.001), compared to the trend among women whose mothers were relatively short (p for trend, 0.221). The results showed a robust and positive association of birth length with breast cancer risk, and may be especially strong in women whose mothers were relatively tall. We found no association of placental weight with risk for breast cancer.
Collapse
Affiliation(s)
- Marie Søfteland Sandvei
- Department of Public Health and General Practice, Norwegian University of Science and Technology, Trondheim, Norway
| | | | | | | | | |
Collapse
|
9
|
Advancing research on endocrine disrupting chemicals in breast cancer: Expert panel recommendations. Reprod Toxicol 2014; 54:141-7. [PMID: 25549947 DOI: 10.1016/j.reprotox.2014.12.015] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2014] [Revised: 12/05/2014] [Accepted: 12/19/2014] [Indexed: 12/19/2022]
Abstract
Breast cancer incidence continues to increase in the US and Europe, a reflection of the growing influence of environment factors that interact with personal genetics. The US Environmental Protection Agency estimates that there are approximately 10,000 endocrine disrupting chemicals among the common daily exposures that could affect the risk of disease. The daunting tasks of identifying, characterizing, and elucidating the mechanisms of endocrine disrupting chemicals in breast cancer need to be addressed to produce a comprehensive model that will facilitate preventive strategies and public policy. An expert panel met to describe and bring attention to needs linking common environmental exposures, critical windows of exposure, and optimal times of assessment in investigating breast cancer risk. The group included investigators with extensive experience in the use of rodent models and in leading population studies and produced a set of recommendations for effective approaches to gaining insights into the environmental origins of breast cancer across the lifespan.
Collapse
|
10
|
The Generation R Study: Biobank update 2015. Eur J Epidemiol 2014; 29:911-27. [PMID: 25527369 DOI: 10.1007/s10654-014-9980-6] [Citation(s) in RCA: 174] [Impact Index Per Article: 17.4] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2014] [Accepted: 12/06/2014] [Indexed: 12/14/2022]
Abstract
The Generation R Study is a population-based prospective cohort study from fetal life until adulthood. The study is designed to identify early environmental and genetic causes and causal pathways leading to normal and abnormal growth, development and health from fetal life, childhood and young adulthood. In total, 9,778 mothers were enrolled in the study. Data collection in children and their parents include questionnaires, interviews, detailed physical and ultrasound examinations, behavioural observations, Magnetic Resonance Imaging and biological samples. Efforts have been conducted for collecting biological samples including blood, hair, faeces, nasal swabs, saliva and urine samples and generating genomics data on DNA, RNA and microbiome. In this paper, we give an update of the collection, processing and storage of these biological samples and available measures. Together with detailed phenotype measurements, these biological samples provide a unique resource for epidemiological studies focused on environmental exposures, genetic and genomic determinants and their interactions in relation to growth, health and development from fetal life onwards.
Collapse
|
11
|
Hofman A, Darwish Murad S, van Duijn CM, Franco OH, Goedegebure A, Ikram MA, Klaver CCW, Nijsten TEC, Peeters RP, Stricker BHC, Tiemeier HW, Uitterlinden AG, Vernooij MW. The Rotterdam Study: 2014 objectives and design update. Eur J Epidemiol 2013; 28:889-926. [PMID: 24258680 DOI: 10.1007/s10654-013-9866-z] [Citation(s) in RCA: 259] [Impact Index Per Article: 23.5] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/21/2013] [Accepted: 11/08/2013] [Indexed: 02/06/2023]
Abstract
The Rotterdam Study is a prospective cohort study ongoing since 1990 in the city of Rotterdam in The Netherlands. The study targets cardiovascular, endocrine, hepatic, neurological, ophthalmic, psychiatric, dermatological, oncological, and respiratory diseases. As of 2008, 14,926 subjects aged 45 years or over comprise the Rotterdam Study cohort. The findings of the Rotterdam Study have been presented in over a 1,000 research articles and reports (see www.erasmus-epidemiology.nl/rotterdamstudy ). This article gives the rationale of the study and its design. It also presents a summary of the major findings and an update of the objectives and methods.
Collapse
Affiliation(s)
- Albert Hofman
- Department of Epidemiology, Erasmus Medical Center, PO Box 2040, 3000 CA, Rotterdam, The Netherlands,
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
12
|
Lohne JJ, Andersen WC, Casey CR, Turnipseed SB, Madson MR. Analysis of stilbene residues in aquacultured finfish using LC-MS/MS. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY 2013; 61:2364-2370. [PMID: 23379635 DOI: 10.1021/jf3045878] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
This analytical method was developed for the determination of three stilbene residues, diethylstilbestrol (DES), dienestrol (DEN), and hexestrol (HEX), in edible tissues of finfish including catfish, salmon, trout, and tilapia. Fortified fish samples were extracted with acetonitrile and further cleaned up using silica solid phase extraction columns. Stilbene residues were separated from matrix components by reversed phase high-performance liquid chromatography on a C8 column and analyzed using a tandem mass spectrometer with negative electrospray ionization. The overall average residue recoveries using post-fortified matrix-matched calibrants were 119, 99, and 104% with %RSDs of 18, 11, and 15% for DEN, DES, and HEX, respectively. Method detection limits of DEN, DES, and HEX in each matrix were found to be at or below 0.21 ng/g, and the limit of quantification averaged 0.3 ng/g and ranged from 0.18 to 0.65 ng/g for all analytes in all matrices.
Collapse
Affiliation(s)
- Jack J Lohne
- Animal Drugs Research Center and ‡Denver Laboratory, U.S. Food and Drug Administration , Denver Federal Center Building 20, West Sixth Avenue and Kipling Boulevard, Denver, Colorado 80225-0087, United States
| | | | | | | | | |
Collapse
|
13
|
Boekelheide K, Blumberg B, Chapin RE, Cote I, Graziano JH, Janesick A, Lane R, Lillycrop K, Myatt L, States JC, Thayer KA, Waalkes MP, Rogers JM. Predicting later-life outcomes of early-life exposures. ENVIRONMENTAL HEALTH PERSPECTIVES 2012; 120:1353-61. [PMID: 22672778 PMCID: PMC3491941 DOI: 10.1289/ehp.1204934] [Citation(s) in RCA: 124] [Impact Index Per Article: 10.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/07/2012] [Accepted: 06/06/2012] [Indexed: 05/17/2023]
Abstract
BACKGROUND In utero exposure of the fetus to a stressor can lead to disease in later life. Epigenetic mechanisms are likely mediators of later-life expression of early-life events. OBJECTIVES We examined the current state of understanding of later-life diseases resulting from early-life exposures in order to identify in utero and postnatal indicators of later-life diseases, develop an agenda for future research, and consider the risk assessment implications of this emerging knowledge. METHODS This review was developed based on our participation in a National Research Council workshop titled "Use of in Utero and Postnatal Indicators to Predict Health Outcomes Later in Life: State of the Science and Research Recommendations." We used a case study approach to highlight the later-life consequences of early-life malnutrition and arsenic exposure. DISCUSSION The environmental sensitivity of the epigenome is viewed as an adaptive mechanism by which the developing organism adjusts its metabolic and homeostatic systems to suit the anticipated extrauterine environment. Inappropriate adaptation may produce a mismatch resulting in subsequent increased susceptibility to disease. A nutritional mismatch between the prenatal and postnatal environments, or early-life obesogen exposure, may explain at least some of the recent rapid increases in the rates of obesity, type 2 diabetes, and cardiovascular diseases. Early-life arsenic exposure is also associated with later-life diseases, including cardiovascular disease and cancer. CONCLUSIONS With mounting evidence connecting early-life exposures and later-life disease, new strategies are needed to incorporate this emerging knowledge into health protective practices.
Collapse
Affiliation(s)
- Kim Boekelheide
- Department of Pathology and Laboratory Medicine, Division of Biology and Medicine, Brown University, Providence, Rhode Island 02912, USA.
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|